Patent 7803788 was granted and assigned to Gilead Sciences on September, 2010 by the United States Patent and Trademark Office.
A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a)